| 12.66 0.2 (1.61%) | 04-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 15.62 |
1-year : | 18.24 |
| Resists | First : | 13.37 |
Second : | 15.62 |
| Pivot price | 12.5  |
|||
| Supports | First : | 12.4 |
Second : | 11.8 |
| MAs | MA(5) : | 12.47 |
MA(20) : | 12.62 |
| MA(100) : | 13.67 |
MA(250) : | 13.84 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 50.8 |
D(3) : | 45.4 |
| RSI | RSI(14): 48.3 |
|||
| 52-week | High : | 15.49 | Low : | 11.8 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CCAP ] has closed below upper band by 32.4%. Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 12.69 - 12.74 | 12.74 - 12.79 |
| Low: | 12.16 - 12.22 | 12.22 - 12.27 |
| Close: | 12.57 - 12.66 | 12.66 - 12.74 |
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Fri, 10 Apr 2026
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Mon, 06 Apr 2026
Crescent Capital BDC: Additional Downside Risks Remain (Rating Downgrade) - Seeking Alpha
Thu, 02 Apr 2026
CCAP SEC Filings - Crescent Capital Bdc Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Wed, 01 Apr 2026
Board of Crescent Capital BDC (NASDAQ: CCAP) backs director slate and E&Y ratification - Stock Titan
Mon, 30 Mar 2026
B. Riley Financial Initiates Coverage on Crescent Capital BDC (NASDAQ:CCAP) - MarketBeat
Mon, 02 Mar 2026
Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 37 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 72.2 (%) |
| Shares Short | 384 (K) |
| Shares Short P.Month | 349 (K) |
| EPS | 0.93 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.1 |
| Profit Margin | 20.6 % |
| Operating Margin | 75.3 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 4.7 % |
| Qtrly Rev. Growth | -12.2 % |
| Gross Profit (p.s.) | 4.53 |
| Sales Per Share | 4.53 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -14.9 % |
| Operating Cash Flow | 75 (M) |
| Levered Free Cash Flow | 48 (M) |
| PE Ratio | 13.61 |
| PEG Ratio | 0 |
| Price to Book value | 0.66 |
| Price to Sales | 2.79 |
| Price to Cash Flow | 6.25 |
| Dividend | 0.41 |
| Forward Dividend | 0 |
| Dividend Yield | 3.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|